Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study (vol 292, pg 1163, 2015)
dc.contributor.author | Turan, GA | |
dc.contributor.author | Eskicioglu, F | |
dc.contributor.author | Sivrikoz, ON | |
dc.contributor.author | Cengiz, H | |
dc.contributor.author | Adakan, S | |
dc.contributor.author | Gur, EB | |
dc.contributor.author | Tatar, S | |
dc.contributor.author | Sahin, N | |
dc.contributor.author | Yilmaz, O | |
dc.date.accessioned | 2024-07-18T12:02:43Z | |
dc.date.available | 2024-07-18T12:02:43Z | |
dc.identifier.issn | 0932-0067 | |
dc.identifier.other | 1432-0711 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/8629 | |
dc.language.iso | English | |
dc.publisher | SPRINGER HEIDELBERG | |
dc.title | Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study (vol 292, pg 1163, 2015) | |
dc.type | Correction |